Draft Report on Carcinogens Monograph on Cobalt and Certain Cobalt Compounds; Availability of Document; Request for Comments; Notice of Meeting, 27178-27179 [2015-11355]
Download as PDF
27178
Federal Register / Vol. 80, No. 91 / Tuesday, May 12, 2015 / Notices
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: May 6, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–11359 Filed 5–11–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Draft Report on Carcinogens
Monograph on Cobalt and Certain
Cobalt Compounds; Availability of
Document; Request for Comments;
Notice of Meeting
The notice announces a
meeting to peer review the Draft Report
on Carcinogens (RoC) Monograph on
Cobalt and Certain Cobalt Compounds.
This document was prepared by the
Office of the Report on Carcinogens
(ORoC), Division of the National
Toxicology Program (DNTP), National
Institute of Environmental Health
Sciences (NIEHS). The peer-review
meeting is open to the public.
Registration is requested for both public
attendance and oral comment and
required to access the webcast.
Information about the meeting and
registration is available at https://ntp.
niehs.nih.gov/go/38853.
DATES:
Meeting: July 22, 2015, 9:00 a.m.
Eastern Daylight Time (EDT) to
adjournment.
Document Availability: Draft
monograph will be available by June 5,
2015, at https://ntp.niehs.nih.gov/go/
38853.
Written Public Comments
Submissions: Deadline is July 8, 2015.
Registration for Attendance and/or Oral
Comments: Deadline is July 15, 2015.
Registration to view the meeting via the
webcast is required.
ADDRESSES: Meeting Location: Rodbell
Auditorium, Rall Building, NIEHS, 111
T.W. Alexander Drive, Research
Triangle Park, NC 27709.
Agency Meeting Web page: The draft
monographs, draft agenda, registration,
and other meeting materials will be
posted at https://ntp.niehs.nih.gov/go/
38853.
Webcast: The URL for viewing the
webcast will be provided to those who
register.
FOR FURTHER INFORMATION CONTACT: Dr.
Lori White, NTP Designated Federal
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:31 May 11, 2015
Jkt 235001
Official, Office of Liaison, Policy and
Review, DNTP, NIEHS, P.O. Box 12233,
MD K2–03, Research Triangle Park, NC
27709. Phone: (919) 541–9834, Fax:
(301) 480–3272, Email: whiteld@
niehs.nih.gov. Hand Delivery/Courier:
530 Davis Drive, Room 2136,
Morrisville, NC 27560.
SUPPLEMENTARY INFORMATION:
Background: The RoC is a
congressionally mandated, sciencebased, public health report that
identifies agents, substances, mixtures,
or exposures (collectively called
‘‘substances’’) in our environment that
pose a cancer hazard for people in the
United States. The NTP prepares the
RoC on behalf of the Secretary of Health
and Human Services.
The NTP follows an established, fourpart process for preparation of the RoC
(https://ntp.niehs.nih.gov/go/rocprocess).
A RoC monograph is prepared for each
candidate substance selected for review
for the RoC. A draft RoC monograph
consists of (1) a cancer evaluation
component that reviews all information
that may bear on a listing decision,
assesses its quality and sufficiency for
reaching a listing decision, applies the
RoC listing criteria to the relevant
scientific information, and recommends
a listing status for the candidate
substance in the RoC and (2) a substance
profile that contains the NTP’s
preliminary listing recommendation and
a summary of the scientific evidence
considered key to reaching that
recommendation.
Cobalt was selected as a candidate
substance following solicitation of
public comment, review by the NTP
Board of Scientific Counselors on April
16—18, 2014, and approved by the NTP
Director (https://ntp.niehs.nih.gov/go/
9741). This meeting is planned for peer
review of the Draft RoC Monograph on
Cobalt and Certain Cobalt Compounds.
Cobalt is a naturally occurring
metallic element that exists in different
forms. It occurs in the environment in
ores where it is combined with other
elements such as arsenic and sulfur.
Pure cobalt is a grey metal and there are
numerous inorganic and organic cobalt
compounds, with varying valence states
and water solubility. The RoC
evaluation includes cobalt metal and
certain cobalt compounds—both water
soluble and poorly soluble
compounds—that can release cobalt
ions in biological fluids. One cobalt
compound that releases cobalt ions,
cobalt sulfate, is listed in the 13th RoC
as reasonably anticipated to be a human
carcinogen (https://ntp.niehs.nih.gov/go/
roc13). The RoC evaluation does not
include cobalt forms that have
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
confounding exposures, such as cobalt
carbides, alloys and radioactive forms of
cobalt or cobalt compounds. It also does
not include Vitamin B12, which does not
release cobalt ions in vivo. Cobalttungsten carbide: powders and hard
metals is listed in the 13th RoC as
reasonably anticipated to be a human
carcinogen and is not included in this
evaluation.
Major uses of cobalt include the
production of cemented carbides,
diamond tools, and superalloys and
other alloys used in a variety of
commercial, industrial, medical and
military applications. Some cobalt
compounds are used as pigments for
coloring glass, ceramics, and pottery. A
more recent use of cobalt is in green
energy (e.g., rechargeable batteries for
electric vehicles and consumer
electronics). People are exposed to
cobalt in workplaces that process cobalt
metals and produce cobalt alloys;
exposure to cobalt in their everyday
lives may also result from implanted
medical devices, consumption of food
and drinking water and, to a lesser
extent, from breathing contaminated air.
Additional information about the review
of cobalt and certain cobalt compounds
for the RoC is available at https://ntp.
niehs.nih.gov/go/730697.
Meeting and Registration: This
meeting is open to the public with time
set aside for oral public comment. The
public may attend the meeting at
NIEHS, where attendance is limited
only by the space available, or view the
webcast. Registration is required to view
the webcast; the URL for the webcast
will be provided in the email
confirming registration. Individuals who
plan to provide oral comments (see
below) are encouraged to register online
at the meeting Web site (https://
ntp.niehs.nih.gov/go/38853) by July 15,
2015, to facilitate planning for the
meeting.
The preliminary agenda and draft
monograph should be posted on the
NTP Web site (https://ntp.niehs.nih.gov/
go/38853) by June 5, 2015. Additional
information will be posted when
available or may be requested in
hardcopy, see FOR FURTHER INFORMATION
CONTACT. Following the meeting, a
report of the peer review will be
prepared and made available on the
NTP Web site. Registered attendees are
encouraged to access the meeting Web
page to stay abreast of the most current
information regarding the meeting.
Visitor and security information is
available at https://www.niehs.nih.gov/
about/visiting/index.cfm. Individuals
with disabilities who need
accommodation to participate in this
event should contact Ms. Robbin Guy at
E:\FR\FM\12MYN1.SGM
12MYN1
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 91 / Tuesday, May 12, 2015 / Notices
phone: (919) 541–4363 or email: guyr2@
niehs.nih.gov. TTY users should contact
the Federal TTY Relay Service at (800)
877–8339. Requests should be made at
least five business days in advance of
the event.
Request for Comments: The NTP
invites written and oral public
comments on the draft monograph. The
deadline for submission of written
comments is July 8, 2015, to enable
review by the peer-review panel and
NTP staff prior to the meeting.
Registration to provide oral comments is
by July 15, 2015, at https://
ntp.niehs.nih.gov/go/38853. Public
comments and any other
correspondence on the draft
monographs should be sent to the FOR
FURTHER INFORMATION CONTACT. Persons
submitting written comments should
include their name, affiliation, mailing
address, phone, email, and sponsoring
organization (if any) with the document.
Written comments received in response
to this notice will be posted on the NTP
Web site, and the submitter will be
identified by name, affiliation, and/or
sponsoring organization.
Public comment at this meeting is
welcome, with time set aside for the
presentation of oral comments on the
draft monograph. In addition to inperson oral comments at the meeting at
the NIEHS, public comments can be
presented by teleconference line. There
will be 50 lines for this call; availability
will be on a first-come, first-served
basis. The lines will be open from 9:00
a.m. until adjournment on July 22, 2015,
and oral comments will be received
only during the formal public comment
period indicated on the preliminary
agenda. Each organization (sponsoring
organization or affiliation) is allowed
one time slot. At least 7 minutes will be
allotted to each speaker, and if time
permits, may be extended to 10 minutes
at the discretion of the chair.
Persons wishing to make an oral
presentation are asked to register online
at https://ntp.niehs.nih.gov/go/38853 by
July 15, 2015, and if possible, to send a
copy of their slides and/or statement or
talking points at that time. Written
statements can supplement and may
expand the oral presentation.
Registration for in-person oral
comments will also be available at the
meeting, although time allowed for
presentation by on-site registrants may
be less than that for registered speakers
and will be determined by the number
of speakers who register on-site.
Background Information on the RoC:
Published biennially, each edition of the
RoC is cumulative and consists of
substances newly reviewed in addition
to those listed in previous editions. The
VerDate Sep<11>2014
17:31 May 11, 2015
Jkt 235001
13th RoC, the latest edition, was
published on October 2, 2014 (available
at https://ntp.niehs.nih.gov/go/roc13).
The 14th RoC is under development.
For each listed substance, the RoC
contains a substance profile, which
provides information on: cancer studies
that support the listing—including those
in humans, animals, and studies on
possible mechanisms of action—
information about potential sources of
exposure to humans, and current
Federal regulations to limit exposures.
Background Information on NTP PeerReview Panels: NTP panels are
technical, scientific advisory bodies
established on an ‘‘as needed’’ basis to
provide independent scientific peer
review and advise the NTP on agents of
public health concern, new/revised
toxicological test methods, or other
issues. These panels help ensure
transparent, unbiased, and scientifically
rigorous input to the program for its use
in making credible decisions about
human hazard, setting research and
testing priorities, and providing
information to regulatory agencies about
alternative methods for toxicity
screening. The NTP welcomes
nominations of scientific experts for
upcoming panels. Scientists interested
in serving on an NTP panel should
provide a current curriculum vita to the
FOR FURTHER INFORMATION CONTACT. The
authority for NTP panels is provided by
42 U.S.C. 217a; section 222 of the Public
Health Service (PHS) Act, as amended.
The panel is governed by the Federal
Advisory Committee Act, as amended (5
U.S.C. Appendix 2), which sets forth
standards for the formation and use of
advisory committees.
Dated: May 6, 2015.
John R. Bucher,
Associate Director, National Toxicology
Program.
[FR Doc. 2015–11355 Filed 5–11–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
27179
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group, Neurobiology of
Motivated Behavior Study Section.
Date: June 2–3, 2015.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications
Place: Mayflower Park Hotel, 405 Olive
Way, Seattle, WA 98101.
Contact Person: Nicholas Gaiano, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5178,
MSC 7844, Bethesda, MD 20892–7844, 301–
435–1033, gaianonr@csr.nih.gov.
Name of Committee: Risk, Prevention and
Health Behavior Integrated Review Group,
Risk, Prevention and Intervention for
Addictions Study Section.
Date: June 4–5, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Dupont Circle Hotel, 1500 New
Hampshire Avenue NW., Washington, DC
20036.
Contact Person: Miriam Mintzer, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive Room 3108,
Bethesda, MD 20892, (301) 523–0646,
mintzermz@csr.nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group, Clinical
and Integrative Diabetes and Obesity Study
Section.
Date: June 4–5, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Hui Chen, MD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20892, 301–435–1044,
chenhui@csr.nih.gov.
Name of Committee: Immunology
Integrated Review Group, Cellular and
Molecular Immunology—A Study Section.
Date: June 4–5, 2015.
Time: 8:30 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Silver Spring, 8777
Georgia Avenue, Silver Spring, MD 20910.
Contact Person: David B Winter, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4204,
MSC 7812, Bethesda, MD 20892, 301–435–
1152, dwinter@mail.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group, Biomedical
Imaging Technology B Study Section.
E:\FR\FM\12MYN1.SGM
12MYN1
Agencies
[Federal Register Volume 80, Number 91 (Tuesday, May 12, 2015)]
[Notices]
[Pages 27178-27179]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-11355]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Draft Report on Carcinogens Monograph on Cobalt and Certain
Cobalt Compounds; Availability of Document; Request for Comments;
Notice of Meeting
SUMMARY: The notice announces a meeting to peer review the Draft Report
on Carcinogens (RoC) Monograph on Cobalt and Certain Cobalt Compounds.
This document was prepared by the Office of the Report on Carcinogens
(ORoC), Division of the National Toxicology Program (DNTP), National
Institute of Environmental Health Sciences (NIEHS). The peer-review
meeting is open to the public. Registration is requested for both
public attendance and oral comment and required to access the webcast.
Information about the meeting and registration is available at https://ntp.niehs.nih.gov/go/38853.
DATES:
Meeting: July 22, 2015, 9:00 a.m. Eastern Daylight Time (EDT) to
adjournment.
Document Availability: Draft monograph will be available by June 5,
2015, at https://ntp.niehs.nih.gov/go/38853.
Written Public Comments Submissions: Deadline is July 8, 2015.
Registration for Attendance and/or Oral Comments: Deadline is July 15,
2015. Registration to view the meeting via the webcast is required.
ADDRESSES: Meeting Location: Rodbell Auditorium, Rall Building, NIEHS,
111 T.W. Alexander Drive, Research Triangle Park, NC 27709.
Agency Meeting Web page: The draft monographs, draft agenda,
registration, and other meeting materials will be posted at https://ntp.niehs.nih.gov/go/38853.
Webcast: The URL for viewing the webcast will be provided to those
who register.
FOR FURTHER INFORMATION CONTACT: Dr. Lori White, NTP Designated Federal
Official, Office of Liaison, Policy and Review, DNTP, NIEHS, P.O. Box
12233, MD K2-03, Research Triangle Park, NC 27709. Phone: (919) 541-
9834, Fax: (301) 480-3272, Email: whiteld@niehs.nih.gov. Hand Delivery/
Courier: 530 Davis Drive, Room 2136, Morrisville, NC 27560.
SUPPLEMENTARY INFORMATION:
Background: The RoC is a congressionally mandated, science-based,
public health report that identifies agents, substances, mixtures, or
exposures (collectively called ``substances'') in our environment that
pose a cancer hazard for people in the United States. The NTP prepares
the RoC on behalf of the Secretary of Health and Human Services.
The NTP follows an established, four-part process for preparation
of the RoC (https://ntp.niehs.nih.gov/go/rocprocess). A RoC monograph is
prepared for each candidate substance selected for review for the RoC.
A draft RoC monograph consists of (1) a cancer evaluation component
that reviews all information that may bear on a listing decision,
assesses its quality and sufficiency for reaching a listing decision,
applies the RoC listing criteria to the relevant scientific
information, and recommends a listing status for the candidate
substance in the RoC and (2) a substance profile that contains the
NTP's preliminary listing recommendation and a summary of the
scientific evidence considered key to reaching that recommendation.
Cobalt was selected as a candidate substance following solicitation
of public comment, review by the NTP Board of Scientific Counselors on
April 16--18, 2014, and approved by the NTP Director (https://ntp.niehs.nih.gov/go/9741). This meeting is planned for peer review of
the Draft RoC Monograph on Cobalt and Certain Cobalt Compounds.
Cobalt is a naturally occurring metallic element that exists in
different forms. It occurs in the environment in ores where it is
combined with other elements such as arsenic and sulfur. Pure cobalt is
a grey metal and there are numerous inorganic and organic cobalt
compounds, with varying valence states and water solubility. The RoC
evaluation includes cobalt metal and certain cobalt compounds--both
water soluble and poorly soluble compounds--that can release cobalt
ions in biological fluids. One cobalt compound that releases cobalt
ions, cobalt sulfate, is listed in the 13th RoC as reasonably
anticipated to be a human carcinogen (https://ntp.niehs.nih.gov/go/roc13). The RoC evaluation does not include cobalt forms that have
confounding exposures, such as cobalt carbides, alloys and radioactive
forms of cobalt or cobalt compounds. It also does not include Vitamin
B12, which does not release cobalt ions in vivo. Cobalt-
tungsten carbide: powders and hard metals is listed in the 13th RoC as
reasonably anticipated to be a human carcinogen and is not included in
this evaluation.
Major uses of cobalt include the production of cemented carbides,
diamond tools, and superalloys and other alloys used in a variety of
commercial, industrial, medical and military applications. Some cobalt
compounds are used as pigments for coloring glass, ceramics, and
pottery. A more recent use of cobalt is in green energy (e.g.,
rechargeable batteries for electric vehicles and consumer electronics).
People are exposed to cobalt in workplaces that process cobalt metals
and produce cobalt alloys; exposure to cobalt in their everyday lives
may also result from implanted medical devices, consumption of food and
drinking water and, to a lesser extent, from breathing contaminated
air. Additional information about the review of cobalt and certain
cobalt compounds for the RoC is available at https://ntp.niehs.nih.gov/go/730697.
Meeting and Registration: This meeting is open to the public with
time set aside for oral public comment. The public may attend the
meeting at NIEHS, where attendance is limited only by the space
available, or view the webcast. Registration is required to view the
webcast; the URL for the webcast will be provided in the email
confirming registration. Individuals who plan to provide oral comments
(see below) are encouraged to register online at the meeting Web site
(https://ntp.niehs.nih.gov/go/38853) by July 15, 2015, to facilitate
planning for the meeting.
The preliminary agenda and draft monograph should be posted on the
NTP Web site (https://ntp.niehs.nih.gov/go/38853) by June 5, 2015.
Additional information will be posted when available or may be
requested in hardcopy, see FOR FURTHER INFORMATION CONTACT. Following
the meeting, a report of the peer review will be prepared and made
available on the NTP Web site. Registered attendees are encouraged to
access the meeting Web page to stay abreast of the most current
information regarding the meeting.
Visitor and security information is available at https://www.niehs.nih.gov/about/visiting/index.cfm. Individuals with
disabilities who need accommodation to participate in this event should
contact Ms. Robbin Guy at
[[Page 27179]]
phone: (919) 541-4363 or email: guyr2@niehs.nih.gov. TTY users should
contact the Federal TTY Relay Service at (800) 877-8339. Requests
should be made at least five business days in advance of the event.
Request for Comments: The NTP invites written and oral public
comments on the draft monograph. The deadline for submission of written
comments is July 8, 2015, to enable review by the peer-review panel and
NTP staff prior to the meeting. Registration to provide oral comments
is by July 15, 2015, at https://ntp.niehs.nih.gov/go/38853. Public
comments and any other correspondence on the draft monographs should be
sent to the FOR FURTHER INFORMATION CONTACT. Persons submitting written
comments should include their name, affiliation, mailing address,
phone, email, and sponsoring organization (if any) with the document.
Written comments received in response to this notice will be posted on
the NTP Web site, and the submitter will be identified by name,
affiliation, and/or sponsoring organization.
Public comment at this meeting is welcome, with time set aside for
the presentation of oral comments on the draft monograph. In addition
to in-person oral comments at the meeting at the NIEHS, public comments
can be presented by teleconference line. There will be 50 lines for
this call; availability will be on a first-come, first-served basis.
The lines will be open from 9:00 a.m. until adjournment on July 22,
2015, and oral comments will be received only during the formal public
comment period indicated on the preliminary agenda. Each organization
(sponsoring organization or affiliation) is allowed one time slot. At
least 7 minutes will be allotted to each speaker, and if time permits,
may be extended to 10 minutes at the discretion of the chair.
Persons wishing to make an oral presentation are asked to register
online at https://ntp.niehs.nih.gov/go/38853 by July 15, 2015, and if
possible, to send a copy of their slides and/or statement or talking
points at that time. Written statements can supplement and may expand
the oral presentation. Registration for in-person oral comments will
also be available at the meeting, although time allowed for
presentation by on-site registrants may be less than that for
registered speakers and will be determined by the number of speakers
who register on-site.
Background Information on the RoC: Published biennially, each
edition of the RoC is cumulative and consists of substances newly
reviewed in addition to those listed in previous editions. The 13th
RoC, the latest edition, was published on October 2, 2014 (available at
https://ntp.niehs.nih.gov/go/roc13). The 14th RoC is under development.
For each listed substance, the RoC contains a substance profile, which
provides information on: cancer studies that support the listing--
including those in humans, animals, and studies on possible mechanisms
of action--information about potential sources of exposure to humans,
and current Federal regulations to limit exposures.
Background Information on NTP Peer-Review Panels: NTP panels are
technical, scientific advisory bodies established on an ``as needed''
basis to provide independent scientific peer review and advise the NTP
on agents of public health concern, new/revised toxicological test
methods, or other issues. These panels help ensure transparent,
unbiased, and scientifically rigorous input to the program for its use
in making credible decisions about human hazard, setting research and
testing priorities, and providing information to regulatory agencies
about alternative methods for toxicity screening. The NTP welcomes
nominations of scientific experts for upcoming panels. Scientists
interested in serving on an NTP panel should provide a current
curriculum vita to the FOR FURTHER INFORMATION CONTACT. The authority
for NTP panels is provided by 42 U.S.C. 217a; section 222 of the Public
Health Service (PHS) Act, as amended. The panel is governed by the
Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), which
sets forth standards for the formation and use of advisory committees.
Dated: May 6, 2015.
John R. Bucher,
Associate Director, National Toxicology Program.
[FR Doc. 2015-11355 Filed 5-11-15; 8:45 am]
BILLING CODE 4140-01-P